2015 Procrastinator’s CE Day
April 25, 2015
Holiday Inn Portland South, Wilsonville, Oregon
PROGRAM SCHEDULE
8:00 – 9:00 AM
Oregon Board of Pharmacy Regulatory Update
1.0 Credit Hours Law – UAN# 0036-9999-15-110-L03-P
This session will provide an in-depth account of regulatory and professional issues being addressed by the Oregon State Board of
Pharmacy. This presentation will include a law update. Additionally, attendees will gain insights regarding their participation as both
public and professional members of the Board.
Learning Objectives:
• Discuss current regulatory issues facing the profession of pharmacy, both locally in Oregon and at the federal level.
• Describe the Board’s role and the professional associations’ role in regulation and the advancement of the profession of
pharmacy.
• Identify resources for pharmacists and technicians to become involved in the advancement of the profession of pharmacy.
Fiona Karbowicz, RPh, Consultant Pharmacist, Oregon Board of Pharmacy
9:00 – 10:00 AM
How Quality Measures will Transform the Role of Pharmacists in Community Pharmacy
1.0 Credit Hours General - UAN# 0036-9999-15-111-L03-P
The Patient Protection and Affordable Care Act contains provisions to incentivize health plan performance on various quality measures
presenting new opportunity for pharmacy. This session will provide background on these incentives measure programs and identify
quality measures that may be applicable to the community pharmacy setting.
Learning Objectives:
• Understand why Medicare Star Ratings and other incentive measure programs matter to health care payors.
• Describe how these programs will drive demand for quality measurement at the pharmacy level.
• Identify quality measures presenting opportunity for community pharmacy.
Adriane Irwin, MS, PharmD, BCACP, Clinical Assistant Professor, Oregon State University College of Pharmacy
10:00 – 11:00 AM
Pharmacogenomics: Current and Future Implications for Pediatric and Aging Patients
1.0 Credit Hour Disease State Management/Drug Therapy - UAN# 0036-9999-15-112-L01-P
Since the discovery of the DNA molecule, the era of genetic medicine has brought along new knowledge, opportunities, and debates. It
was found early in history that variations in enzymes contribute to a range of drug concentrations and to potential differences in
patient outcomes. The field of pharmacogenetics is rapidly growing and institutions have begun to harness the information from
infancy and apply it throughout the patient’s lifetime to improve drug therapy. In this program, we will discuss a variety of topics
including clinical applications in institutional and ambulatory care practice and the expanding role of the pharmacist.
Learning Objectives:
• Define pharmacogenomics, pharmacogenetics and personalized medicine.
• Explain the difference between genotype and phenotype.
• Describe examples of clinical pharmacogenetics applied in pediatric and geriatric populations.
• Recognize guidelines and resources related to pharmacogenetics.
• Discuss the role of the pharmacist in applying pharmacogenomics to patient care.
Ben Kong, PharmD, Clinical Pharmacist, Providence Portland Medical Center
11:00 AM – 12:30 PM
Co-morbidities in Aging HIV Patients
1.5 Credit Hours AIDS Therapy – UAN# 0036-9999-15-113-L02-P
HIV has transformed from an acute, deadly illness to a long-term chronic condition due to the advent of medications with less side
effects and greater efficacy.
(continued)
Pharmacists have an important role in recognizing the issues impacting people living with HIV/AIDS over the age of 50, and helping
them maintain and improve their current state of health. This presentation discusses the management of the most commonly seen
non-AIDS related co-morbidities and provides useful information for pharmacists when taking care of the aging HIV patient.
Learning Objectives:
• Discuss the management of non-AIDS co-morbidities in aging HIV patients.
• Identify useful information for HIV medication management.
• Discuss age-related factors that impact adherence and solutions for improved medication adherence.
• List at least three quick HIV medication resources.
Marie Dorsey, PharmD, AAHIVP, Inpatient Staff Pharmacist at Sacred Heart Medical Center
12:30 – 1:15 PM
Lunch
1:15 – 2:45 PM
Medical Marijuana and the Pharmacology of Cannabinoids
1.5 Credit Hours General Pharmacy – UAN# 0036-9999-15-114-L04-P
The number of medical marijuana dispensaries in Oregon grew dramatically in 2014 creating new and rapidly changing implications for
health care professionals. In anticipation that pharmacists will be increasingly asked to council patients using medical marijuana we will
review the current approved uses of this therapy, consider the risks versus benefits and the potential for adverse drug-induced side
effects. We will review the neuropharmacology of cannabinoids, recent advances in our understanding of the endocannabinoid system
and discuss the challenges of predicting how natural cannabinoids in the Cannabis sativa plant work to modulate endogenous cell
signaling pathways for therapeutic advantage.
Course Objectives:
• Describe the approved uses, and rationale for the use, of medical marijuana.
• Evaluate the therapeutic benefits of medical marijuana versus risk to target organs such as the cardiopulmonary and central
nervous systems.
• Describe potential drug interactions.
• Describe the pharmacology of the cannabinoids.
Jane Ishmael, PhD, Associate Professor of Pharmacology, OSU College of Pharmacy
2:45 – 3:45 PM
New Legislation and Rule Changes - How They Affect You
1.0 Credit Hour Law – UAN# 0036-9999-15-115-L03-P
This panel will provide attendees with the timeliest information related to new legislation and rules changes that impact pharmacy
practice in Oregon.
Learning Objectives:
• Identify proactive measures and practices that licensees can implement to comply with new legislation and regulations.
• Cite recent changes in pharmacy laws and their impact on daily practice.
• Discuss current regulatory issues facing the profession of pharmacy in Oregon.
Jennifer Davis, PharmD, RPh, Pharmacy Manager, Fred Meyer
Joshua Free, PharmD, MBA, Pharmacy Director, Consonus Pharmacy Services
Kenneth Wells, RPh, Corporate Business Development Manager, OSU College of Pharmacy
3:45 – 5:15 PM
The Transition into Pharmacist Based Solutions for Transitions of Care
1.5 Credit Hours Patient Safety – UAN# 0036-9999-15-116-L05-P
This CE will review patient safety issues faced during transitions between different areas in healthcare. There is mounting evidence
that transitions of care represent a vulnerable time for patients to fall into medication related errors. There is also a growing body of
evidence that pharmacists can play a large role in helping patients during transitions. This CE will review and discuss different
strategies that can be implemented for pharmacists to be involved in transitions of care.
Learning Objectives:
• Define different types of care transitions.
• Identify patient safety issues that may arise during transitions.
• Develop strategies to improve patient safety through transitions of care.
Bradly Winter, PharmD, PGY-1 Pharmacy Practice Resident, Samaritan Health Services.
5:15 PM
Meeting Concludes
nd
Oregon State Pharmacy Association
147 SE 102 Avenue, Portland, Oregon 97216 503.582.9055 [email protected] www.oregonpharmacy.org